Indication
Congenital toxoplasmosis
Congenital toxoplasmosis is an infectious disease of the developing fetus or newborn resulting from transplacental transmission of the obligate intracellular protozoan *Toxoplasma gondii*, typically following an acute, primary maternal infection during pregnancy. Read more about Congenital toxoplasmosis
4 drugs 4 manufacturers
Drugs that treat it
Common Congenital toxoplasmosis therapies.
SULFADIAZINE
SULFADIAZINE
SULFADIAZINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCongenital toxoplasmosis is an infectious disease of the developing fetus or newborn resulting from transplacental transmission of the obligate intracellular protozoan *Toxoplasma gondii*, typically following an acute, primary maternal infection during pregnancy.
The parasite primarily damages the central nervous system, eyes, and reticuloendothelial system, causing pathology that ranges from asymptomatic subclinical infection to severe fetal morbidity or fetal demise.
Defining clinical features classically encompass the triad of chorioretinitis, hydrocephalus, and intracranial calcifications, frequently accompanied by microcephaly, seizures, sensorineural hearing loss, and systemic signs such as hepatosplenomegaly, jaundice, and thrombocytopenia.
While transmission risk rises in later gestation, maternal infections acquired earlier in pregnancy typically correlate with more severe fetal disease and long-term neurocognitive impairment.
- nih.gov
Congenital toxoplasmosis is an infectious disease of the developing fetus or newborn resulting from transplacental transmission of the obligate intracellular protozoan *Toxoplasma gondii*, typically following an acute, primary maternal infection during pregnancy The parasite primarily damages the central nervous system, eyes, and reticuloendothelial system, causing pathology that ranges from asymptomatic subclinical infection to severe fetal morbidity or fetal demise
- nih.gov
Congenital toxoplasmosis is an infectious disease of the developing fetus or newborn resulting from transplacental transmission of the obligate intracellular protozoan *Toxoplasma gondii*, typically following an acute, primary maternal infection during pregnancy
- cdc.gov
Congenital toxoplasmosis is an infectious disease of the developing fetus or newborn resulting from transplacental transmission of the obligate intracellular protozoan *Toxoplasma gondii*, typically following an acute, primary maternal infection during pregnancy
- cdc.gov
The parasite primarily damages the central nervous system, eyes, and reticuloendothelial system, causing pathology that ranges from asymptomatic subclinical infection to severe fetal morbidity or fetal demise Defining clinical features classically encompass the triad of chorioretinitis, hydrocephalus, and intracranial calcifications, frequently accompanied by microcephaly, seizures, sensorineural hearing loss, and systemic signs such as hepatosplenomegaly, jaundice, and thrombocytopenia
- nih.gov
While transmission risk rises in later gestation, maternal infections acquired earlier in pregnancy typically correlate with more severe fetal disease and long-term neurocognitive impairment
Personalize your experience
Follow Congenital toxoplasmosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.